Siren LLC’s Veradermics Inc MANE Stock Holding History

Siren LLC’s Portfolio MANE Stock Details MANE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204M	Buy	1,655,374 +150,000	+10%	+$14.1M	4.12%	4
2026 Q1	$95.1M	Buy	+1,505,374	New	+$75.9M	2.64%	10

Other funds holding MANE

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Siren LLC's MANE Position: Q2 2026 in Review

Siren LLC increased its Veradermics Inc (MANE) stake by 10% in Q2 2026, buying an estimated $14.1M and bringing the position to 1,655,374 shares worth $204M. The position accounts for 4.12% of the portfolio, ranked #4.

Siren LLC first reported a position in MANE in Q1 2026 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

Siren LLC held 1,655,374 shares of Veradermics Inc worth $204M as of Q2 2026.
Siren LLC bought 150,000 Veradermics Inc shares in Q2 2026, an estimated $14.1M.
Veradermics Inc made up 4.12% of Siren LLC's portfolio in Q2 2026, its #4 holding.
Siren LLC first reported a position in Veradermics Inc in Q1 2026 and has held it in 2 quarters since.
164 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Siren LLC's 13F filing for Q2 2026, filed 13 Aug 2026.